Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate
about
Advances and challenges in malaria vaccine developmentIdentification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)Circumsporozoite protein as a potential target for antimalarialsMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaStructural Insights into Serine-rich Fimbriae from Gram-positive BacteriaShape change in the receptor for gliding motility in Plasmodium sporozoitesA Method for Producing Protein Nanoparticles with Applications in VaccinesVaccine platforms combining circumsporozoite protein and potent immune modulators, rEA or EAT-2, paradoxically result in opposing immune responsesMotility precedes egress of malaria parasites from oocystsInsights into the Immunological Properties of Intrinsically Disordered Malaria Proteins Using Proteome Scale Predictions.Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.Chelation of Ca²⁺ ions by a peptide from the repeat region of the Plasmodium falciparum circumsporozoite protein.Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, MaliImmunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.Combining portable Raman probes with nanotubes for theranostic applications.High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle.IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.The expanded amelogenin polyproline region preferentially binds to apatite versus carbonate and promotes apatite crystal elongationAntibody and B cell responses to Plasmodium sporozoites.False positive circumsporozoite protein ELISA: a challenge for the estimation of the entomological inoculation rate of malaria and for vector incrimination.Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail ChallengeSero-epidemiological evaluation of Plasmodium falciparum malaria in SenegalA Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.Analysis of the conformation and function of the Plasmodium falciparum merozoite proteins MTRAP and PTRAMPReversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion DomainsA Comprehensive Analysis of Plasmodium Circumsporozoite Protein Binding to Hepatocytes.Binding of aldolase and glyceraldehyde-3-phosphate dehydrogenase to the cytoplasmic tails of Plasmodium falciparum merozoite duffy binding-like and reticulocyte homology ligandsA comparison of Plasmodium falciparum circumsporozoite protein-based slot blot and ELISA immuno-assays for oocyst detection in mosquito homogenates.Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.Unraveling protein-protein interactions in clathrin assemblies via atomic force spectroscopy.T1BT* structural study of an anti-plasmodial peptide through NMR and molecular dynamicsOvercoming allelic specificity by immunization with five allelic forms of Plasmodium falciparum apical membrane antigen 1.Acquired antibodies to merozoite antigens in children from Uganda with uncomplicated or severe Plasmodium falciparum malaria.Malaria parasite pre-erythrocytic infection: preparation meets opportunity.NOS2 variants reveal a dual genetic control of nitric oxide levels, susceptibility to Plasmodium infection, and cerebral malaria.Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis.Malaria adhesins: structure and function.Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends.
P2860
Q21032463-EF57016B-10DB-4958-9D55-628B51D86CA5Q21034050-DA62BC7D-AC7F-4108-920F-A61D55E0722DQ26314437-120831FE-7739-47FF-8473-BE85EDED00DDQ26772878-5BA61AE2-BEA9-469F-ADB4-7865EC3F6679Q27662848-ED736F93-625E-45FB-8963-2B08DBE586BAQ27675475-97D49FDB-2B36-4FA1-B136-2A9E77F13F46Q28550575-6DD2677A-134A-4F05-9762-7CFF808C3F93Q28740832-DB4F406D-C00E-4609-87CF-5BEA2C0878A9Q30044113-A94BABB2-9DAE-4680-9C73-99CCD9023A6DQ30380793-7E139684-8910-4510-B720-092B559259DEQ30390705-87ED6C4B-5980-4BFE-899A-24AC9938A6CDQ33756504-50065ED8-750C-4C5D-94E1-8B7482EAB0FFQ33916707-AEFE2D10-5978-4E18-B9CF-B6C640D731CDQ33925720-29876D2A-CB72-4F53-A9BD-0042E5E15E80Q33964986-0E0C2B9A-9E2C-4D8F-A7FC-CB9DA0D722C0Q34171724-1998BC6C-69C3-45DF-8B62-ED58B34623B0Q34232909-3F40CC7A-C4FE-4E09-9564-204E7EDC3417Q34341570-9A008102-5A79-4238-A5C0-1B497B32E998Q34400813-CD283D15-D31A-4D24-8714-44723EC6DA13Q34488231-78FBE60E-440C-4EA3-AC5E-F19F13CE7846Q34530938-9C038977-C46E-4271-9436-E541CD957A44Q35177723-5F8F77B2-187A-41F2-B4F7-48A3D69EC612Q35683366-90079B2A-B8E8-43E9-9839-4D504F737F34Q35853662-6859522B-E831-46B5-8381-F2F16C92B40AQ35925784-5259357E-3F0E-4542-8892-CB590C02EB95Q35941001-03F3DD78-B8D3-4633-8920-521D6AF57E0BQ36053524-7D7C1C91-5CAE-41AF-899D-02011C4CDC48Q36112823-FF2B2D70-0BA4-4D41-A07B-6E61DC31D0B1Q36250608-B6E886CD-10D1-476B-9FE7-3512304F61E8Q36287262-42160C76-75F4-4FD5-8210-64B640A2DDE3Q36330007-BA650007-E361-4CF9-B425-6AF23204869AQ36718104-16DC3ADE-4EF0-41E3-9A1E-A46558ACF4DCQ36752043-5F70F476-CBB0-4534-AF49-B83D5004E5F3Q36826951-B3036B94-20AF-47FD-B3AB-A23C27318851Q37124766-5A9C9D9A-98D3-4FD1-889F-97EB97A5B920Q37533146-84FDDEF2-8D67-4487-99E3-DE73BDE98F1EQ37643913-42FB3561-5C8F-418F-815D-2FA2451F7605Q37681902-82E123A6-27B7-43E7-845F-9E753A040DCAQ37728315-3F49B5F7-69BD-41F2-9F72-2176511E9CEBQ37762275-4C717F4E-D83B-449E-8CAD-32DA42A39F08
P2860
Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@ast
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@en
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@nl
type
label
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@ast
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@en
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@nl
prefLabel
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@ast
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@en
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Structure of the Plasmodium fa ...... ding malaria vaccine candidate
@en
P2093
Brent House
Darrell E Hurt
Jacob Lebowitz
Jacqueline Glen
Karine Reiter
Matthew L Plassmeyer
Merrit Hickman
Nicholas J MacDonald
Onyinyechukwu Uchime
Paul D Smith
P2860
P304
P3181
P356
10.1074/JBC.M109.013706
P407
P577
2009-09-25T00:00:00Z